ArticleJournal of experimental & clinical cancer research : CR2026
Reciprocal signaling-metabolic crosstalk between fibroblasts and tumor cells drives cetuximab tolerance in head and neck cancers.
Engy Vigneron et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.